News

Business Insider12d
23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron Pharmaceuticals will acquire ... Read next BI Tech Memo An icon in the shape of an angle pointing down.
The rise and fall of 23andMe
Regeneron is buying bankrupt genetic testing firm 23andMe, which helped usher in the era of consumer DNA test kits nearly two ...
The Pittsburgh Jewish Chronicle19d
The 20th century was very good for these Jewish icons. Is the Golden Age really over?
Mel Brooks, Betty Friedan, Norman Mailer and Leonard Bernstein are the “unruly” subjects of David Denby’s 'Eminent Jews.' ...
Regeneron Shares Slide on Mixed Trial Data for Smoker's Lung Drug
(Reuters) -Regeneron shares fell nearly 18% on Friday after its experimental drug for patients with a type of lung condition ...
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the ...
Biotechnology Company Regeneron Buying 23andMe for $256 Million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...
CNN12d
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the companies said Monday. Regeneron said it will comply with 23andMe’s ...
U.S. News & World Report12d
Biotechnology Company Regeneron Buying 23andMe for $256 Million
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...